|
1
|
Ackerman LV: Verrucous carcinoma of the
oral cavity. Surgery. 23:670–678. 1948.PubMed/NCBI
|
|
2
|
Arduino PG, Carrozzo M, Pagano M, Gandolfo
S and Broccoletti R: Verrucous oral carcinoma: Clinical findings
and treatment outcomes in 74 patients in Northwest Italy. Minerva
Stomatol. 57:335–339. 339–341. 2008.PubMed/NCBI
|
|
3
|
Impola U, Uitto VJ, Hietanen J, Hakkinen
L, Zhang L, Larjava H, Isaka K and Saarialho-Kere U: Differential
expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9) and
metalloelastase (MMP-12) in oral verrucous and squamous cell
cancer. J Pathol. 202:14–22. 2004. View Article : Google Scholar
|
|
4
|
Medina JE, Dichtel W and Luna MA:
Verrucous-squamous carcinomas of the oral cavity. A
clinicopathologic study of 104 cases. Arch Otolaryngol.
110:437–440. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Walvekar RR, Chaukar DA, Deshpande MS, Pai
PS, Chaturvedi P, Kakade A, Kane SV and D'Cruz AK: Verrucous
carcinoma of the oral cavity: A clinical and pathological study of
101 cases. Oral Oncol. 45:47–51. 2009. View Article : Google Scholar
|
|
6
|
Yeh CJ: Treatment of verrucous hyperplasia
and verrucous carcinoma by shave excision and simple cryosurgery.
Int J Oral Maxillofac Surg. 32:280–283. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Patel KR, Chernock RD, Zhang TR, Wang X,
El-Mofty SK and Lewis JS Jr: Verrucous carcinomas of the head and
neck, including those with associated squamous cell carcinoma, lack
transcriptionally active high-risk human papillomavirus. Hum
Pathol. 44:2385–2392. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Quan H, Tang Z, Zhao L, Wang Y, Liu O, Yao
Z and Zuo J: Expression of αB-crystallin and its potential
anti-apoptotic role in oral verrucous carcinoma. Oncol Lett.
3:330–334. 2012.PubMed/NCBI
|
|
9
|
Lin HP, Wang YP and Chiang CP: Expression
of p53, MDM2, p21, heat shock protein 70, and HPV 16/18 E6 proteins
in oral verrucous carcinoma and oral verrucous hyperplasia. Head
Neck. 33:334–340. 2011.
|
|
10
|
Wang YH, Tian X, Liu OS, Fang XD, Quan HZ,
Xie S, Gao S and Tang ZG: Gene profiling analysis for patients with
oral verrucous carcinoma and oral squamous cell carcinoma. Int J
Clin Exp Med. 7:1845–1852. 2014.PubMed/NCBI
|
|
11
|
Liu O, Zhang H, Wang Y, Quan H, Zhang J,
Zhou J, Zuo J, Tang J, Fang X, Wang W, et al: Stereology study of
oral verrucous carcinoma. J Buon. 17:343–349. 2012.PubMed/NCBI
|
|
12
|
Gomes CC and Gomez RS: MicroRNA and oral
cancer: Future perspectives. Oral Oncol. 44:910–914. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Allegra A, Alonci A, Campo S, Penna G,
Petrungaro A, Gerace D and Musolino C: Circulating microRNAs: New
biomarkers in diagnosis, prognosis and treatment of cancer
(review). Int J Oncol. 41:1897–1912. 2012.PubMed/NCBI
|
|
14
|
Etheridge A, Lee I, Hood L, Galas D and
Wang K: Extracellular microRNA: A new source of biomarkers. Mutat
Res. 717:85–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang B, Hsu SH, Majumder S, Kutay H, Huang
W, Jacob ST and Ghoshal K: TGFbeta-mediated upregulation of hepatic
miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Oncogene. 29:1787–1797. 2010. View Article : Google Scholar
|
|
16
|
Guo JX, Tao QS, Lou PR, Chen XC, Chen J
and Yuan GB: miR-181b as a potential molecular target for
anticancer therapy of gastric neoplasms. Asian Pac J Cancer Prev.
13:2263–2267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cervigne NK, Reis PP, Machado J, Sadikovic
B, Bradley G, Galloni NN, Pintilie M, Jurisica I, Perez-Ordonez B,
Gilbert R, et al: Identification of a microRNA signature associated
with progression of leukoplakia to oral carcinoma. Hum Mol Genet.
18:4818–4829. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brito JA, Gomes CC, Guimarães AL, Campos K
and Gomez RS: Relationship between microRNA expression levels and
histopathological features of dysplasia in oral leukoplakia. J Oral
Pathol Med. 43:211–216. 2014. View Article : Google Scholar
|
|
19
|
Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P
and Hu W: MicroRNA-181a sensitizes human malignant glioma U87MG
cells to radiation by targeting Bcl-2. Oncol Rep. 23:997–1003.
2010.PubMed/NCBI
|
|
20
|
Yang CC, Hung PS, Wang PW, Liu CJ, Chu TH,
Cheng HW and Lin SC: miR-181 as a putative biomarker for lymph-node
metastasis of oral squamous cell carcinoma. J Oral Pathol Med.
40:397–404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barinaga M: Death by dozens of cuts.
Science. 280:32–34. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding J, Liu B, He Y, Yuan X, Tian D, Ji B,
Wang L, Wu L, Dong H, Wang J, et al: LRIG1 improves
chemosensitivity through inhibition of BCL-2 and MnSOD in
glioblastoma. Cell Biochem Biophys. 71:27–33. 2015. View Article : Google Scholar
|
|
23
|
Xu Y, Soo P, Walker F, Zhang HH, Redpath
N, Tan CW, Nicola NA, Adams TE, Garrett TP, Zhang JG and Burgess
AW: LRIG1 extracellular domain: Structure and function analysis. J
Mol Biol. 427:1934–1948. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Huang CF, Zhang L, Ma SR, Zhao ZL, Wang
WM, He KF, Zhao YF, Zhang WF, Liu B and Sun ZJ: Clinical
significance of Keap1 and Nrf2 in oral squamous cell carcinoma.
PLoS One. 8:e834792013. View Article : Google Scholar
|
|
26
|
Sun ZJ, Zhang L, Hall B, Bian Y, Gutkind
JS and Kulkarni AB: Chemopreventive and chemotherapeutic actions of
mTOR inhibitor in genetically defined head and neck squamous cell
carcinoma mouse model. Clin Cancer Res. 18:5304–5313. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bian Y, Hall B, Sun ZJ, Molinolo A, Chen
W, Gutkind JS, Waes CV and Kulkarni AB: Loss of TGF-β signaling and
PTEN promotes head and neck squamous cell carcinoma through
cellular senescence evasion and cancer-related inflammation.
Oncogene. 31:3322–3332. 2012. View Article : Google Scholar
|
|
28
|
Ma SR, Wang WM, Huang CF, Zhang WF and Sun
ZJ: Anterior gradient protein 2 expression in high grade head and
neck squamous cell carcinoma correlated with cancer stem cell and
epithelial mesenchymal transition. Oncotarget. 6:8807–8821. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu W, Shan X, Wang T, Shu Y and Liu P:
miR-181b modulates multidrug resistance by targeting BCL2 in human
cancer cell lines. Int J Cancer. 127:2520–2529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu BH, Xiong XP, Jia J and Zhang WF:
MicroRNAs: New actors in the oral cancer scene. Oral Oncol.
47:314–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lynam-Lennon N, Maher SG and Reynolds JV:
The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos
Soc. 84:55–71. 2009. View Article : Google Scholar
|
|
33
|
Henao-Mejia J, Williams A, Goff LA, Staron
M, Licona-Limón P, Kaech SM, Nakayama M, Rinn JL and Flavell RA:
The microRNA miR-181 is a critical cellular metabolic rheostat
essential for NKT cell ontogenesis and lymphocyte development and
homeostasis. Immunity. 38:984–997. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Neel JC and Lebrun JJ: Activin and TGFβ
regulate expression of the microRNA-181 family to promote cell
migration and invasion in breast cancer cells. Cell Signal.
25:1556–1566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Visone R, Veronese A, Rassenti LZ, Balatti
V, Pearl DK, Acunzo M, Volinia S, Taccioli C, Kipps TJ and Croce
CM: miR-181b is a biomarker of disease progression in chronic
lymphocytic leukemia. Blood. 118:3072–3079. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ouyang YB, Lu Y, Yue S and Giffard RG:
miR-181 targets multiple Bcl-2 family members and influences
apoptosis and mitochondrial function in astrocytes. Mitochondrion.
12:213–219. 2012. View Article : Google Scholar :
|
|
37
|
Lu F, Zhang J, Ji M, Li P, Du Y, Wang H,
Zang S, Ma D, Sun X and Ji C: miR-181b increases drug sensitivity
in acute myeloid leukemia via targeting HMGB1 and Mcl-1. Int J
Oncol. 45:383–392. 2014.PubMed/NCBI
|
|
38
|
Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu
Z and You Y: hsa-mir-181a and hsa-mir-181b function as tumor
suppressors in human glioma cells. Brain Res. 1236:185–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Singh BB, Chandler FW Jr, Whitaker SB and
Forbes-Nelson AE: Immunohistochemical evaluation of bcl-2
oncoprotein in oral dysplasia and carcinoma. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 85:692–698. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Su L, Wang Y, Xiao M, Lin Y and Yu L:
Up-regulation of survivin in oral squamous cell carcinoma
correlates with poor prognosis and chemoresistance. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod. 110:484–491. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yi W, Haapasalo H, Holmlund C, Järvelä S,
Raheem O, Bergenheim AT, Hedman H and Henriksson R: Expression of
leucine-rich repeats and immunoglobulin-like domains (LRIG)
proteins in human ependymoma relates to tumor location, WHO grade
and patient age. Clin Neuropathol. 28:21–27. 2009. View Article : Google Scholar : PubMed/NCBI
|
